BP drug reduces MS symptoms

A drug used to treat BP and heart failure has been found to reduce the symptoms of multiple sclerosis (MS), UK research suggests.

The discovery that the drug amiloride, a potassium-sparing diuretic, can reduce the degeneration of nerve tissue offers fresh hope for MS sufferers.

For this study, the researchers hypothesised that the acid-sensing ion channel (ASIC1) could play a key role in the development of MS.

ASIC1 works by sensing acid levels around the cell and lets in sodium and calcium molecules into cells. This function is an important part of the process of sensing pain and touch.

Using mice with a condition that mimics some aspects of the human form of MS, the researchers found that the ASIC1 channel contributes to the degeneration of the axon, which in turns leads to the nerve damage caused by MS.

The next step of the study was to identify drugs that could be used to target the ASIC1 channel.
The heart failure drug amiloride is a known ASIC1 antagonist that is safe and licensed.

MS mice were then injected daily with amiloride for weeks. Those that were injected with the drug showed markedly reduced axonal degeneration compared with mice that had not been injected.


Visit the Nature Medicine website

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Medical examiners to scrutinise deaths in community settings

The MDU's Dr Kathryn Leask explains how the expansion of the medical examiner system...

Person receiving a COVID-19 booster

COVID-19 booster campaign to start on 5 September, NHS England says

The COVID-19 booster programme will begin in care homes and for housebound patients...

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

BMA sign

BMA elects new deputy chair of England GP committee and chair of Scottish council

Dr David Wrigley has been elected as new deputy chair of the BMA's GP committee in...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...